Dates: September 28, 2012
Location: Chicago, IL
Web Page URL: www.hematology.org/Meetings/Consultative-Hematology-Course/8501.aspx
Topics Covered: The program will focus on non-malignant hematology.
Objectives: The one-day program, geared toward North American community practitioners, will cover commonly encountered clinical problems that arise in everyday practice and require the expertise of a hematologist.
Who Should Attend: Hematologist and Oncologist
Agenda: The program will use case-based presentations and interactive discussions. The hands-on course will be led by faculty familiar with consultative practice issues.
Registration Information: Registration for the 2012 CHC is limited to practicing hematologists in North America. If you are not a current ASH member and you plan to attend the 2012 CHC only, you must register at the "Non-Member" rate. If you are neither a current ASH member nor a member of SAS partnering society and you plan to attend both 2012 CHC and SAS, you must register at the "Non-Member" rate. Online at www.hematology.org/Meetings/Consultative-Hematology-Course/8501.aspx Payment by American Express, MasterCard, or Visa is accepted. By Mail Mail the registration form (available at www.hematology.org/sas12) and payment by check only to: ASH Administration P.O. Box 791210 Baltimore, MD 21279-1210 For Questions: Contact ASH Customer Relations at 202-776-0544 or email email@example.com.
Fees: CHC only ranges from $120- $175. CHC+SAS ranges from $345-$575.
Continuing Education: No
Dec 11, 2013 - Many patients with myeloproliferative neoplasms without mutations in the Janus kinase 2 gene (JAK2) or in the thrombopoietin receptor gene (MPL) have mutations in the CALR gene encoding calreticulin, according to two studies published online Dec. 10 in the New England Journal of Medicine. The research was published to coincide with presentation at the annual meeting of the American Society of Hematology, held from Dec. 7 to 10 in New Orleans.
Dec 14, 2011
Oct 2, 2014
Jan 2, 2013
Dec 17, 2012